Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

OIG: Medicare May End Up Overpaying for ESRD Drugs

The Office of Inspector General recommends that the Centers for Medicare & Medicaid Services develop "a more accurate method" for estimating changes in the prices of drugs such as those used to treat end-stage renal disease.

Please enter your comment below:
Please enter the text below: